U.S. market Closed. Opens in 1 day 6 hours 31 minutes

APVO | Aptevo Therapeutics Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/A3.11M12.29M4.31M32.42M
Cost of Revenue567.00K901.00K18.99M17.85M19.93M
Gross Profit-567.00K2.21M-6.70M-13.54M12.50M
Operating Expenses28.88M31.75M33.69M31.80M40.96M
Selling, General & Admin11.77M13.87M14.70M13.95M16.20M
Research & Development17.11M17.88M18.99M17.85M24.76M
Other Operating ExpensesN/A-1.53M-8.01M-1.32M-2.10M
Operating Income-28.88M-28.64M-21.40M-27.49M-40.96M
Other Expenses / Income10.23M35.66M-8.01M-3.43M-2.10M
Before Tax Income-18.65M7.01M-29.41M-30.92M-43.06M
Income Tax ExpensesN/A-35.66M-2.10M-12.47M-2.62M
Net Income-17.41M42.67M-27.31M-18.45M-40.45M
Interest ExpensesN/AN/AN/AN/AN/A
Basic Shares Outstanding278.06K116.36K106.54K77.07K66.30K
Diluted Shares Outstanding278.06K115.97K106.54K77.07K66.30K
EBITDA-28.31M-27.74M-20.26M-26.09M-39.53M
EBITDA Margin0.00%-890.82%-164.79%-605.43%-121.91%
EBIT-17.41M7.01M-29.41M-30.92M-43.06M
EBIT Margin0.00%225.24%-239.25%-717.64%-132.82%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙